Skip to main content

Peer Review reports

From: An open-label clinical trial of oral transmucosal haloperidol and oral transmucosal olanzapine in the treatment of terminal delirium at home

Original Submission
8 Aug 2021 Submitted Original manuscript
23 Dec 2021 Reviewed Reviewer Report - Jonathan Silcock
27 Dec 2021 Reviewed Reviewer Report - Antje Blank
27 Dec 2021 Reviewed Reviewer Report - Muslim Syed
4 Jan 2022 Reviewed Reviewer Report - Arnold Zermansky
10 Feb 2022 Author responded Author comments - Xiao Juan Lyu
Resubmission - Version 2
10 Feb 2022 Submitted Manuscript version 2
25 Feb 2022 Reviewed Reviewer Report - Muslim Syed
8 Mar 2022 Reviewed Reviewer Report - Antje Blank
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
27 Mar 2022 Editorially accepted
14 Apr 2022 Article published 10.1186/s13063-022-06238-4

You can find further information about peer review here.

Back to article page